Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis
Clinical trial NCT01058005 · TERMINATED
Trial details
- NCT number
- NCT01058005
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2012-04-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.